Application Guidelines Krafttak mot kreft 2019 "Norwegian Cancer Society National Group of Expertise on Lung Cancer/ Pancreatic Cancer" ...
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Application Guidelines
Krafttak mot kreft 2019
“Norwegian Cancer Society
National Group of Expertise on
Lung Cancer/ Pancreatic Cancer”CONTENTS
1 Introduction ...................................................................................................................................... 3
1.1 Purpose of these guidelines ...................................................................................................... 3
1.2 About the Norwegian Cancer Society ....................................................................................... 3
1.3 User involvement in research ................................................................................................... 3
2 Funding scheme .............................................................................................................................. 3
2.1 Eligibility .................................................................................................................................... 3
2.2 What is funded .......................................................................................................................... 4
3 The application process ................................................................................................................... 4
3.1 Application ................................................................................................................................. 4
Section 1 – Project description ........................................................................................................ 4
Section 2 – Project administration ................................................................................................... 5
Section 3 – Project partners and participants .................................................................................. 6
Section 4 – Project duration and budget ......................................................................................... 6
Section 5 – Project information ....................................................................................................... 7
Section 6 – Statement of acknowledgement ................................................................................... 7
3.2 Submission ................................................................................................................................ 7
3.3 Evaluation ................................................................................................................................. 7
Scientific evaluation ......................................................................................................................... 7
User evaluation ................................................................................................................................ 9
3.4 Decision .................................................................................................................................... 9
3.5 Feedback ................................................................................................................................ 10
3.6 Impartiality ............................................................................................................................... 10
3.7 Confidentiality .......................................................................................................................... 10
4 Grant Terms and Conditions ......................................................................................................... 11
5 Contact Details .............................................................................................................................. 11
6 Recommended Links ..................................................................................................................... 11
7 Appendix ........................................................................................................................................ 11
7.1 Call announcement ................................................................................................................. 12
7.2 CV template ............................................................................................................................ 14
7.3 Contract template .................................................................................................................... 16
7.4 The Norwegian Cancer Society’s ethical principles and guidelines ....................................... 23
21 INTRODUCTION
1.1 PURPOSE OF THESE GUIDELINES
These guidelines explain the Krafttak for kreft 2019 application - and evaluation process, with an aim
to ensure quality and impartiality throughout the process.
To get your application right the first time, you will need to read these guidelines carefully. We also
recommend that you familiarize yourself with the contents of the guidelines’ Appendix.
1.2 ABOUT THE NORWEGIAN CANCER SOCIETY
The Norwegian Cancer Society’s aim is to work to prevent and fight cancer, and to ensure the best
quality of life for patients and their families. We work continuously to improve public awareness of the
prevention and treatment of cancer. Through research, prevention, information, support, advice and
lobbying, we fight cancer locally, nationally and globally. See our Strategy 2016-2019 for more
information.
1.3 USER INVOLVEMENT IN RESEARCH
A more user-oriented cancer care is highlighted as a separate goal in the Norwegian Cancer Society´s
strategy. The main premise is that user involvement positively affects the quality of health care,
contributes to more relevant cancer research, and makes research more accessible.
The Norwegian Cancer Society focuses on the end users of research results. User involvement is
particularly relevant for cancer-related patient- and practice-based research. This also includes basic
cancer research, which has a potential long-term impact on patients and their next of kin.
We strongly encourage including users as active participants in research projects, either as
consultants or collaborators. See our user involvement resource page for more information.
2 FUNDING SCHEME
The “Krafttak for kreft” funding scheme will award funds to establish two «National Groups of
Expertise», one for lung cancer and one for pancreatic cancer. The funding scheme is aimed to
stimulate cooperation across different research disciplines and contribute to the translation of basic
knowledge and methodology into knowledge that significantly can impact the lives of seriously ill
patients. Successful applicants will become “The Norwegian Cancer Society
National Group of Expertise on Lung/Pancreatic Cancer”.
2.1 ELIGIBILITY
To be eligible to apply for a grant through this funding scheme, you must:
• Hold a doctoral degree or other equivalent qualification
• Be associated with a Norwegian university, university college, hospital, or other institution with
research as part of its activities.
Project managers with an active grant from the Norwegian Cancer Society are not excluded from
applying.
Moreover, your research project must:
• Be cancer relevant and relevant to the scientific remit of the call
• Be in accordance with the research strategy of your project owner institution
32.2 WHAT IS FUNDED
You can apply for grants in the range of NOK 10 to 15 million for a project period of up to five years.
The funding is awarded as a support to the group in the form of an open grant. Grants can be used to
cover expenses involving, for instance, personnel, networking and running costs.
In this call Ph.D positions may be included in the budget.
Researcher positions
For early career researchers and senior researchers with a doctoral degree and at least one
completed postdoctoral period. You can apply for a researcher position for yourself and/or unnamed
candidates.
Postdoctoral researcher positions
For unnamed candidates with a completed doctoral degree. Candidates must have successfully
defended his/her thesis prior to employment.
PhD positions
For unnamed candidates with a completed master’s degree, or equivalent.
Technical positions
For laboratory technicians, study nurses, statistical personnel, or others that will offer technical
assistance to the research project.
Running costs
To cover general costs related to the research project, including supplies, analyses, conference fees,
travel, publications costs, minor equipment, etc. Can also cover project specific services on an hourly
basis.
Note that the Norwegian Cancer Society does not fund institutional overhead costs. The project owner
institution must cover all institutional costs beyond what is offered.
3 THE APPLICATION PROCESS
3.1 APPLICATION
You must submit your application online using our grants management system, ApplicationWeb.1
The application deadline is September 20, 2019 at 13.00.
You may only submit one project application. The application, including uploads, must be
completed in English.
The application is made up of five sections in which you must input/upload all your application
information.2 All uploads are mandatory unless otherwise stated.
SECTION 1 – PROJECT DESCRIPTION
In this section, you must upload your project description. In 10 pages or less, including figures and
references, address the following:
1 We recommend using the web browser Google Chrome.
2
Uploads must not exceed the requested number of pages or 10MB. Use Arial 10 (9 for references), 2 cm margins and single
spacing. Number all pages. Show the last name and initials of the project manager in a header or footer on all pages. Only PDF-
files will be accepted.
4• Current knowledge including important knowledge gap(s) within the field (based on systematic
reviews or meta-analysis, if applicable)
• A clear description of the project’s objectives (research questions, hypothesis, cancer
relevance and potential impact in relation to the knowledge gaps)
• Methodological approach (describe and give a rationale for selected methodologies)
• Calculation of statistical power (projects involving laboratory animals or human subjects)
• Data management plan (if applicable)
• Project plan including tentative milestones
• Dissemination and communications strategy
• Ethical considerations (if applicable)
• User involvement
• Potential involvement of commercial actor(s) (if applicable)
• Project infrastructure and organization. Specification of the need for each position applied for.
State clearly which activities will be conducted during the project period, who will be
responsible for the various work packages, and where the actual work will be conducted. If the
project manager holds a main position at another institution, describe how the project is
established at the prospective project owner institution, and how the supervision of possible
scientific employees will be maintained.
SECTION 2 – PROJECT ADMINISTRATION
In this section, you must input information about your project owner institution, your project
administrator and yourself, the project manager.
Project Owner Institution
The project owner institution is legally and economically responsible for fulfilling the terms and
conditions of a Norwegian Cancer Society research grant. Norwegian universities, university colleges,
hospitals and other institutions with research as part of their activities are eligible project owner
institutions. The project owner institution may also be referred to as the applicant institution,
prospective grantee institution, or grantee institution.
Project Administrator
The project administrator is an employee of the project owner institution who has the authority to
commit the institution to fulfill the legal and economic obligations on the behalf of the project owner
institution. The project administrator is responsible for approving the application, including the budget,
prior to submission. If a grant is awarded, the administrative responsibility must be fulfilled; accepting
the grant in ApplicationWeb and thereby accepting the terms and conditions described in the project
contract. If applicable, prior to the transfer of funds the project administrator is responsible for
submitting collaboration agreement(s) with all project partners.
Project Manager
The project manager is the principal investigator/scientist responsible for submitting the application in
ApplicationWeb, ensuring scientific progression and project completion as well as submitting
requested reports. The project manager is also referred to as the applicant.
In completing this section, you must upload the following:
• A four-page CV. We strongly encourage you to use the provided CV template (see Appendix).
• A list of relevant publications going back seven years (excluding maternity/paternity leave, sick
leave, military leave etc.). In the case of shared authorships, the authors’ names must appear
in the same order as in the original article. Original scientific articles must be clearly separated
from other publications such as reviews, books/parts of books, and popular scientific articles.
Publications that are “in-press” may be included.
For applicants who are initiating their careers as independent researchers, we strongly recommend
uploading a recommendation letter. The letter should, in no more than one page, describe your
scientific qualifications and potential for leading a prospective research group.
5SECTION 3 – PROJECT PARTNERS AND PARTICIPANTS
In this section, you must input information about your project partners and project participants.
Project Partners
Project partners are external collaborators with a central and obligated contribution to the project. For
these partners we require CV and publication list, in addition to a collaboration agreement prior to the
transfer of funds. Project partners can be institutions, companies and other types of enterprise,
represented by a named individual associated with the organization, that will be under obligation to
contribute to the project, by performing R&D activities and/or providing financing, and/or that will be
granted rights to the project. The role of partners is considered to be so essential to project
implementation that any changes in the composition of the partners will require the prior written
approval of the Norwegian Cancer Society.
The competency and participation of the partners are important factors when assessing project quality,
and may play a decisive part in the decision to grant funding to the project. All partners, Norwegian as
well as non-Norwegian, must be entered in the application form. You must upload a four-page CV
and five-page publication list describing the last five years for all project partners.
The Project Owner must enter into written collaboration agreements with all partners. This applies to
both Norwegian and international partners. Should your application be granted funding, all
collaboration agreements must be submitted within three months after the Norwegian Cancer Society
has sent the contract to the Project Owner.
Project Participants
Project participants include all individuals playing an active role in the project. In this context, “active
role” means that the individual will be taking part in one or more work packages, participating in the
management of the project or contributing in another way to the implementation of the project. All
named individuals must consent to being listed as project participants.
You are to submit CVs for the key researchers participating in the project. How many CVs that
makes will depend on your project. Keep in mind that the CVs are there to assist the experts when
they review the application, and it is therefore important to include CVs for researchers who will
contribute to the project in a significant way. On the other hand, it is not wise to include too many, as it
can make it difficult for the experts who will be assessing the application to find the information that is
relevant.
SECTION 4 – PROJECT DURATION AND BUDGET
In this section, you must enter the estimated start and end dates for your research project, a total
project budget, and specify current and/or expected funding to your research project and yourself.
We require a total project budget in whole NOK, rounded up to the nearest thousand. On the revenue
side, enter funding from the Norwegian Cancer Society, own financing and contributions from other
research funders (current and/or expected). On the expense side, enter the project’s total payroll costs
for researcher positions and technical positions, as well as running costs and other costs.
You must use your project owner institution’s own payroll cost rates (including salary, social security
tax and social benefits). Some projects may require specific expertise that entails higher payroll costs.
If this applies to your research project, you must specify why in your application. Consult with your
project administrator if you have questions concerning your institution’s payroll cost rates.
You may apply for part-time researcher and technical positions, but note the following:
• Research positions may be 20% to 100% per year.
• Ph.D positions or postdoctoral researcher positions must be 50% to 100% per year and
fulfill legal requirement
• Technical positions may be 20% to 100% per year.
• If you apply for a part-time position, you must specify why in the project description.
6The project administrator must approve the budget before you submit your application. An unrealistic
or incomplete budget will affect the assessment of the proposal.
SECTION 5 – PROJECT INFORMATION
In this section, you must input a series of information about your research project. Here you provide
information about the theme of your research project, and enter a Norwegian title and summary of
your project.
In the project summary, you must describe the background, objective, methodology, and impact of
your research project. You must also describe how you will implement user involvement in your
research project. You must define who the users are and how they will be involved in the project. If
you believe that user involvement is not relevant to your project, you must justify why it is not relevant.
You must also enter information about your research project’s clinical data. For projects that require
approval from the Regional Committees for Medical and Health Research Ethics (REC) and/or the
Norwegian Centre for Research Data (NSD), you may upload REC and/or NSD documentation, and/or
a protocol synopsis.
In this section, you must also describe the innovation potential of your research project.
SECTION 6 – STATEMENT OF ACKNOWLEDGEMENT
Before submitting your proposal, you must confirm that the project administrator, on behalf of the
project owner institution, approves your application.
3.2 SUBMISSION
When you submit your application, you will receive a confirmation email. Prior to the application
deadline, you may re-open, modify, and re-submit your application as many times as you want. You
will receive a confirmation email each time you re-submit your application.
3.3 EVALUATION
SCIENTIFIC EVALUATION
Applications are distributed, as they are received, to the peer review committee.
The Norwegian Cancer Society Krafttak mot kreft call has one peer review committee, made up of
appropriately qualified international experts.
The peer review committee evaluates research proposals from a scientific point of view using a set of
predefined assessment criteria, outlined in Table 1.
Table 1.
Is the proposed project relevant for cancer patients (short/ long term)? An assessment of direct or
1 Cancer relevance indirect relevance to cancer biology, prevention, diagnosis, treatment or management of cancer,
and/or relevance to patient care and health services. (Scored yes/no)
2 Relevance to the Is the proposed project relevant for the call? An assessment of direct relevance to the
call establishment of a Group of expertise on either lung or pancreatic cancer.
Application quality. Presentation of scientific background, objectives and content (research
3 Scientific quality
proposal/hypothesis) of the project.
7Originality. Does the project contribute to significant theoretical and/or methodological advances
and/or development of new scientific knowledge and practices in the field?
Methodological approach. Relevance of the proposed methods to answer the hypotheses and
scientific questions, including the breadth of methodological approaches, level of effort.
Innovation potential. The potential for developing new innovative products and services.
How qualified is the project manager and the project team (including collaborators) to conduct the
proposed project? An assessment of:
the project manager’s expertise and experience within the field of research
the project manager's relevant publication record
4 Qualifications of the the degree to which the project manager and project group are part of a research
project manager and environment that has the competence and required resources needed to ensure the success
project group of the project
the project manager experience as a project manager and/or supervisor
are the co-partners relevant to the project?
the project manager's independence as a researcher (published work, mobility)
Interdisciplinary collaboration
international cooperation will be positively weighted, when relevant
To what extent is the project plan and resource requirements adapted to the tasks of the project?
An assessment of:
5 Feasibility
the likelihood of drawing reliable conclusions from expected results and selected method(s)
current pilot data
is the budget realistic and sensible?
To what extent will the research results contribute to new knowledge and/or respond to an
identified knowledge gap that may have a potential impact on prevention and/or treatment of
6 Impact cancer patients (short or long term)? The impact of the project may be assessed from the
perspective of both patient, services and society. An assessment of:
relevant user involvement
assessment of the dissemination and communication plan of the project/results
7 National To what extent will the project utilize the national research expertise, promote national networking
cooperation and and contribute to a beneficial national division of labour.
national division
of labour
8 Strategic support
The degree of support and priority in the project owner institution, including own funding
and importance
Table 2.
Research of internationally high standard of high interest; most likely to be published in top international
7 Outstanding
journals; internationally highly recognized scientists
Research of internationally high standard of great interest; expected that the research can be published
6 Excellent
in high impact international journals; leading scientists in Norway
Research of international standard, research of interest; expected that the research will be published in
5 Very good
high impact journals; scientists with a very good reputation
Research of acceptable, international standard, expected that the research will be published in well-
4 Good
known specialized journals; scientists with a good reputation
3 Fairly good Research of fair international standard which is of minor interest
2 Weak Research of fair/low standard that is of very little interest
Inadequate projects without interest or significance, or projects that are too poorly described to be
1 Poor
evaluated
All committee members conduct an individual evaluation of each research proposal. Two committee
members conduct an in-depth evaluation. They give a grade for each assessment criterion, an overall
grade, and write an evaluation text. The remaining committee members perform a general assessment
and give an overall grade.
8The committee members’ individual project assessments provide the basis for the peer review
committee meetings, in which the committee members discuss each project proposal. The committee
gives a grade for each assessment criteria 3 to 6 according to the grading scale in table 2 (an overall
grade in which criteria 3 and 4 carry double weight). Criteria 7 and 8 will be given a short, written
assessment. The committee writes an overall evaluation text taking all criteria into account.
The peer review committee presents its list of nominations, including a ranking of projects, grades, and
evaluation texts, along with suggested funding, to the board of the Norwegian Cancer Society.
USER EVALUATION
In line with the overall goals of the Norwegian Cancer Society, user representation is implemented as
part of the assessment process to increase the impact and relevance (short -and long term) of the
funded research projects.
User representatives review all research proposals sent to the Norwegian Cancer Society. Two user
representatives are appointed to the peer review committee. One user representative conducts an in-
depth assessment, the other a general assessment. The project manager’s structured summary of
his/her research proposal forms the basis for the user representatives’ assessment.
The user representatives’ task is to assess whether user involvement is relevant to the project, and if
so, to what degree it is adequately secured. The user representatives rank the proposals according to
given criteria by using a grading scale from 1 to 7, presented in Table 3.
Table 3.
Users are involved from the design phase and through the whole research process (when relevant), and they
7
are members of a permanent user advisory group with regular meetings
6 Users are members of a permanent user advisory group with regular meetings
5 The research group has started to formalize user involvement with concrete ideas and plans for the project
Plans for user involvement are insufficient or there is some, but inadequate, contact with users or a user
4
organization
3 Vague intentions for user involvement
2 Misinterpretation of user involvement
1 There is no plan for user involvement
The user representatives’ individual project assessments provide the basis for their joint
recommendation to the peer review committees. The user representatives’ recommendation must
include an overall grade and evaluation text for each research proposal.
The user representatives present their assessments to the peer review committee, with emphasis on
the highest ranked proposals. The peer review committee takes the user assessments into
consideration in their final ranking of proposals. In the case of two equally scored projects, the peer
review committee is encouraged to prioritize projects with the higher user score.
3.4 DECISION
According to the statutes of the Norwegian Cancer Society Article 3-7, the board is the Norwegian
Cancer Society’s appropriating body. The board makes its final decision based on the peer review
committee’s ranking lists.
9The board can award additional funds to projects that are highly relevant to the Norwegian Cancer
Society’s strategic goals, given that the peer review committee consider the projects fundable (overall
grade of 4.5 or higher).
3.5 FEEDBACK
You will be notified of the outcome of your application by email in December 2019. The decision email
will include the individual assessment criteria grades, the overall grade, and the peer review
committee’s evaluation text.
Successful applicants and their project administrators will receive an email with further details
regarding the terms and conditions for research grants. The project administrators are responsible for
formally accepting grants.
3.6 IMPARTIALITY
According to the statutes of the Norwegian Cancer Society § 10-5 regarding impartiality, the following
applies.
A person who has an honorary post in the Norwegian Cancer Society cannot take part in processes or
decision-making that may affect himself directly, or his relatives, and the person concerned may have
pronounced personal or economic interests in the case.
Committee members and user representatives are obligated to report any relationship they have with
applicants or fellowship candidates. Any partiality and non-participation is recorded and presented to
the board of the Norwegian Cancer Society.
Committee members and user representatives are automatically disqualified from evaluating research
proposals if they themselves, family members, or other near relations are partners in the project or if
they have a professional collaboration with the applicant or any of the key partners.
Other possible grounds for declaring conflicts of interest include the following:
• the committee member or user representative has published together with persons
participating in the project
• the committee member or user representative has professional or personal conflicts with
persons participating in the project
• the committee member or user representative has been supervising someone participating in
the project
• the committee member or user representative is a party in another case that is in direct
competition with the proposal
Committee members and user representatives may claim partiality on the grounds of personal
reasons. This must be respected even if it is not evident that such partiality exists.
Neither committee members nor user representatives are permitted to contact applicants concerning
their submitted proposals during the evaluation process.
In cases where a user representative declares partiality, a deputy representative is assigned.
3.7 CONFIDENTIALITY
All members of the peer review committee and the user representatives must sign a confidentiality
agreement. The committee members and user representatives have a legal duty neither to disclose
any sensitive information acquired during the evaluation process, nor reveal the results of the
evaluation process.
104 GRANT TERMS AND CONDITIONS
The terms and conditions for research grants are specified in the contract template (see Appendix).
5 CONTACT DETAILS
For questions, please contact us at forskningsadministrasjon@kreftforeningen.no.
Please mark the e-mail “Krafttak mot kreft 2019”.
Regarding the call
Ann Charlotte Andersen: Telephone: 455 06 635 Switchboard: 214 94 921
Regarding user involvement in research projects
Janina Lassila, mobile: 900 32 397
Technical support
Mustafa Waleed Saleh, mobile: 980 79 426
6 RECOMMENDED LINKS
• The Norwegian Cancer Society’s Strategy 2016-2019
• The Norwegian Cancer Society’s user involvement resource page
7 APPENDIX
117.1 CALL ANNOUNCEMENT
CALL ANNOUNCEMENT
Krafttak mot kreft 2019: “Norwegian Cancer Society
National Group of Expertise on Lung/Pancreatic Cancer”
Key information
Application deadline September 20, 2019 at 13.00
Committee review October/November 2019
Decision December 2019
Funding period Up to 5 years
Funding amount NOK 10 to 15 million
Scientific remit
The Norwegian Cancer Society’s aim is to work to prevent and fight cancer, and to ensure the best
quality of life for patients and their families. We work continuously to improve public awareness of the
prevention and treatment of cancer. Through research, prevention, information, support, advice and
lobbying, we fight cancer locally, nationally and globally. See the Norwegian Cancer Society’s
strategy for more information.
At present we see large variations in survival rates between various diagnostic groups. A priority to the
Norwegian Cancer Society is to increase the research and competence on cancers with low survival
rates. By this commitment, The Norwegian Cancer Society aims to stimulate to increased research
activity and expertise on lung cancer and pancreatic cancer.
The aim of the call is to build a “Norwegian Cancer Society National Group of Expertise” for the
research on lung cancer and pancreatic cancer. The application must clarify how you will be able to
contribute to improve the research field in a national perspective by using the national research
expertise, promote national networking and contribute to an appropriate national work-sharing. The
application needs to clarify what will make the group into a “National Group of Expertise” and how the
group of expertise will continue to exist after the period of funding. It is of importance that the
application explains how the group of expertise intend to make visible and credit the Norwegian
Cancer Society. The Norwegian Cancer Society expects a regular dialogue with the centre in the
period of funding.
The Norwegian Cancer Society will award funds to establish two “National Groups of Expertise”, one
for lung cancer and one for pancreatic cancer. We encourage relevant communities to collaborate.
Successful applicants will become “The Norwegian Cancer Society National Group of Expertise on
Lung /Pancreatic cancer”.
The NOK 30 million made available through this call was raised in the 2019 Krafttak mot
kreft campaign which focused on cancers with low survival rates.
Eligibility
Research groups dedicated to research on lung cancer or pancreatic cancer are eligible to apply for
funds in this call.
12The Groups of Expertise are encouraged to include more than one research group including scientists
from different disciplines and different institutions. The funding scheme is aimed to stimulate
cooperation across different research disciplines and contribute to the translation of basic knowledge
and methodology into knowledge that significantly can impact the lives of seriously ill patients.
It is required that the institutions themselves prioritize the field of research and clarify their own efforts
in the building of the National Group of Expertise. The degree of own funding and other resources will
be weighted in the evaluation.
The project manager must:
• Hold a doctoral degree or other equivalent qualification
• Be associated with a Norwegian university, university college, hospital, or other institution with
research as part of its activities.
Project managers with an active grant from the Norwegian Cancer Society are not excluded from
applying.
What is funded
The funding is awarded as a support to the group in the form of an open grant. The funds may be
used to cover expenses involving, for instance, personnel, networking and associated running costs.
In this call Ph.D degrees may be included in the budget.
The Norwegian Cancer Society does not fund institutional overhead costs, and the project owner
institution must cover all institutional costs beyond what is offered.
Before you begin your application
Please ensure you read:
o Application Guidelines Krafttak mot kreft 2019
Other useful links:
o The Norwegian Cancer Society’s Strategy 2016-2019
o The Norwegian Cancer Society’s user involvement resource page
Contact information
For questions, please contact us at forskningsadministrasjon@kreftforeningen.no.
Please mark the e-mail “Krafttak mot kreft 2019”.
Regarding the call
Ann Charlotte Andersen, mobile: 45 50 66 35 Switchboard: 21 49 49 21
Regarding user involvement in research projects
Janina Lassila, mobile: 900 32 397
Technical support
Mustafa Waleed Alqaisy, mobile: 980 79 426
137.2 CV TEMPLATE
(download word-file)
CURRICULUM VITAE WITH TRACK RECORD
PLEASE NOTE:
All items marked with * must be completed.
The template is based on the CV and track record used in ERC and the Research Council of Norway. The
maximum page limit is 4 pages.
Please use the following font and alignment instructions: Arial 10 (9 for references), standard margins and single
spacing. The CV must be uploaded as a PDF-document.
ROLE IN PROJECT
Project manager ☐ Collaborator ☐
PERSONAL INFORMATION
*Family name, First name:
*Date of birth: dd.mm.yyyy
*Sex:
*Nationality:
Researcher unique identifier(s) (ORCID, Researcher ID, etc.):
URL for personal web site:
*EDUCATION
yyyy PhD:
Name of Faculty/Department, Name of University/Institution, Country
yyyy Master
Name of Faculty/Department, Name of University/Institution, Country
*CURRENT AN D P R E V I O U S POSITIONS
yyyy-yyyy Current Position
Name of Faculty/Department, Name of University/Institution/Country
yyyy-yyyy Previous position held
Name of Faculty/Department, Name of University/Institution/Country
FELLOWSHIPS AND AWARDS (if applicable)
yyyy-yyyy Name of Faculty/Department/Centre, Name of University/Institution/Country
yyyy Award received from Name of Institution/Country
yyyy-yyyy Scholarship, Name of Faculty/Department/Centre, Name of
University/Institution/Country
MOBILITY (research stays abroad lasting more than three months) (if applicable)
yyyy-yyyy Name of Faculty/Department/Centre, Name of University/Institution/Country
Award received from Name of Institution/Country
SUPERVISION OF GRADUATE STUDENTS AND RESEARCH FELLOWS (if applicable)
yyyy-yyyy Number of Postdocs/PhD/Master Students
Name of Faculty/Department/Centre, Name of University/Institution/Country
14TEACHING ACTIVITIES (if applicable)
yyyy-yyyy Teaching position – Topic, Name of University/Institution/Country
ORGANISATION OF SCIENTIFIC MEETINGS (if applicable)
yyyy Please specify your role and name of event/number of participants/Country
INSTITUTIONAL RESPONSIBILITIES (if applicable)
yyyy-yyyy Member of a Committee/Graduate Student Advisor etc.
Name of University/Institution/Country
COMMISSIONS OF TRUST (if applicable)
yyyy-yyyy Scientific Advisory Board/Review Board/Review panel member/Editorial
Board/Scientific Advisory Board/ Reviewer/Scientific Evaluation/etc.
Name of University/Institution/Country
MEMBERSHIPS OF SCIENTIFIC SOCIETIES (if applicable)
yyyy-yyyy Member, research network etc.
MAJOR COLLABORATIONS (if applicable)
Name of collaborators, Topic, Name of Faculty/Department/Centre, Name of
University/Institution/Country
CAREER BREAKS (if applicable)
Exact dates Please indicate the reason and duration in months.
Track record
In the track record, please list:
1. The total number of publications during the career (For early Career scientists: list also
peer reviewed conference proceedings etc.)
2. List up to ten publications, from the last ten years, in major international peer-reviewed
multi-disciplinary scientific journals and/or in the leading international peer-reviewed
journals, peer-reviewed conferences proceedings and/or monographs of their respective
research fields (For early Career scientists: highlighting those without the presence as co-
author of their PhD supervisor. Indicating for each paper the number of citations
(excluding self- citations) they have attracted (if applicable)
3. Research monographs and any translations thereof (if applicable)
4. Granted patent(s) (if applicable)
5. Invited presentations to peer-reviewed, internationally established conferences and/or
international advanced schools (if applicable)
6. Organisation of international conferences in the field of the applicant (membership in the
steering and/or organising committee) (if applicable)
7. Prizes/ Awards/ Academy memberships (if applicable)
8. Major contributions to the early careers of excellent researchers (if applicable)
157.3 CONTRACT TEMPLATE
TEMPLATE FOR PROJECT CONTRACT
THE NORWEGIAN CANCER SOCIETY'S KRAFTTAK MOT KREFT
2019 “NORWEGIAN CANCER SOCIETY NATIONAL GROUP OF
EXPERTISE ON LUNG/PANCREATIC CANCER”
${Date}
PROJECT CONTRACT NO. ${applicationID}-${year}
for the project
${project title}
between
The Norwegian Cancer Society
and
${responsible institution}
1. Project information
ApplicationID: ${applicationID}
Project title: ${project title}
Responsible applicant institution: ${responsible institution}
Administrator responsible for the application at ${responsible institution}:
${full name, administrator responsible}
Project manager: ${full name, project manager}
Call announcement: Krafttak mot Kreft 2019: “Norwegian Cancer Society National Group of Expertise
on Lung/Pancreatic Cancer”
Processed in peer review committee: ${expert group}
Popular science presentation:
$ {Popular science explanation}
2. Granted application
${applicationID and title}
3. Definitions
Project Owner Institution
The project owner institution is the applicant and as such is legally and financially liable for the terms
and conditions associated with any possible grant being fulfilled. The project owner institution is
responsible for the project being carried out with respect to the contract. A project owner institution
may be a Norwegian university, university college, research institute, healthcare enterprise and other
public institutions having research as a part of their activities.
16Project Administrator
The project administrator is an employee at the project owner institution who is duly authorised to
represent and obligate the institution legally and financially with respect to the Norwegian Cancer
Society. The project administrator will approve the application, including the budget, before
submission. The project administrator is also responsible for accepting any possible grant, entering
into the project contract and collaboration agreements.
Project Manager
The project manager shall on behalf of the project owner institution attend to the scientific progress
and execution of the project, as well as the reporting. This individual is responsible for submitting the
electronic application via the Norwegian Cancer Society's ApplicationWeb.
Project Partner
An institution, business or enterprise that is a central, obligated participant in the project that
possesses scientific, technical and/or financial resources.
4. Financial framework, project period and disbursement of payments
The project ${project title} has been granted NOK ${amount} for the period ${year-month-day} to
${year-month-day}. The project start can be postponed to ${date}, for a later project start an
application must be made to the Norwegian Cancer Society.
The award includes VAT. and other fees that accrue during the project period such as holiday
allowances, employers' contributions and pension schemes.
The employer responsibilities lie with the project owner institution, which is also responsible for the
disbursement of operating funds and wages.
Disbursement of payments
The amount granted will as a general rule be disbursed quarterly during the project period, with the
first payment (double) in the second quarter. Payment is predicated upon collaboration agreements
with central, committed project partners in the project having been signed and submitted (cf. Point 3.
Definition of project partner). In those cases where it is relevant, a revised project description with an
approved budget must also be submitted.
Disbursement of payments may be halted if the Norwegian Cancer Society finds that the execution of
the project deviates significantly from the contract or becomes necessary on other grounds.
5. Preconditions and obligations upon acceptance of funds from the Norwegian
Cancer Society
By accepting a grant through the Norwegian Cancer Society’s ApplicationWeb, the project
administrator has acknowledged that the project owner institution accepts the terms and conditions
that appear in this project contract as well as the content in the documents Application Guidelines
Krafttak mot kreft 2019 and The Norwegian Cancer Society’s Ethical Guidelines.
The project owner institution must follow applicable laws and regulations, other public regulation,
ethical guidelines and recognised quality standards and norms for good research practices. The
Norwegian Cancer Society makes it a precondition that all mandatory approvals exist that are required
for execution of the project.
The grant is given under the precondition that the project owner or project manager has not for the
past 10 years received or expects to receive support from the tobacco industry. This includes
enterprises, groups of companies and the like if production or sales encompasses to a significant
extent on-going revenue from the production and/or sale of clearly cancer-causing substances such as
tobacco.
The Norwegian Cancer Society may request of the responsible institution inspection of its accounting,
including complete documentation, that shows the use of the funds awarded by the Norwegian Cancer
Society.
17In the event of any possible contradiction between this project contract and the Norwegian Cancer
Society’s Application Guidelines Krafttak mot kreft 2019 or collaboration agreements between the
project owner institution and the Norwegian Cancer Society, this document shall take precedence.
Project execution
The project must be carried out with respect to the project description and any possible other
agreements that have been entered into between the parties, including the payment disbursement
plan. The funds can only be used for those purposes that are specified in the application.
The project owner institution must ensure that everyone who performs work in the project respects the
rights and obligations that follow from the contract.
The Norwegian Cancer Society will not provide compensation for any possible additional costs due to
leaves of absence.
Handling of deviations
The project owner institution must report in writing without undue delay to the Norwegian Cancer
Society as regards significant deviations from the project description. The Norwegian Cancer Society
will evaluate the deviation reporting and provide written feedback on the outcome.
If the funds have not been used with respect to the project description and contract, then repayment
may be required.
Double financing
If the project manager receives offers of funds for execution of all or parts of the same project, during
the same space of time, then the project owner institution is obligated to notify the Norwegian Cancer
Society with an explanation of how the total project costs will be distributed between the different
financing sources. The Norwegian Cancer Society may require that the project owner institution
decline all or parts of the Norwegian Cancer Society’s grant.
Remaining funds
If at the end of the project period there are leftover funds for wages or operation, then the project
owner institution must enter into a dialogue with the Norwegian Cancer Society concerning any
possible redisposition of such funds. The Norwegian Cancer Society may require repayment of
remaining funds.
6. Projects with project partners
The project owner institution is responsible for the project partners always being acquainted with the
relevant parts of the contract.
Any possible changes to the project partners in the project must be approved by the Norwegian
Cancer Society.
Collaboration agreements
The project owner institution is obligated to enter into collaboration agreements that govern the mutual
rights and obligations of the parties. Such collaboration agreements must exist prior to the
disbursement of funds from the Norwegian Cancer Society.
The project owner institution is responsible for the collaboration agreements according with the terms
and conditions defined in the contract.
7. Reporting
A report concerning the results achieved and deviations from the original application must be
submitted by the project manager once each year. In the event of significant deviations, see point 5.
18In the progress report, the project manager must provide information on the status of the project,
employees involved in the project, scientific publications, on the execution of activities with respect to
the progress plan and budget, as well as account for any possible deviations and their consequences.
At the end of the project, the project manager must submit a report that summarises the results from
the entire project period. The Norwegian Cancer Society must approve the final report and may, as
needed, submit a request concerning a follow-up report.
The final report must contain a popular science summary. If the popular science presentation is not
adequate in terms of its form and content, then the Norwegian Cancer Society may request that it be
reformulated.
The reports will be initiated by the Norwegian Cancer Society and must be responded to via
ApplicationWeb within the given deadline.
An approved progress report is a precondition for further disbursements of grant payments. Lacking
reporting can also have consequences for any possible new projects that are applied for with the
Norwegian Cancer Society.
Breaches of obligations that concern reporting may be regarded as significant breaches which give the
Norwegian Cancer Society a basis for cancelling the contract.
The project owner institution must inform the Norwegian Cancer Society on an on-going basis of
research results connected with the project having a nature that provides commercialisation
possibilities.
8. Incorporeal rights, property rights, exploitation, etc.
The project owner institution and any possible project partners must secure themselves the rights for
commercial exploitation of the project results, and must if necessary enter into agreements with
owners, employees (including those with multiple employment relationships), subcontractors and
others in order to achieve this.
This securing of the rights involves no limitation in the protection of the originator's nonmaterial
interests pursuant to the Norwegian Copyright Act, and poses no impediment to remuneration
arrangements being able to be agreed upon for originators corresponding to those that apply for
patentable employee inventions in accordance with the Norwegian Act Respecting the Right to
Employees' Inventions.
An overarching goal is for the research funds from the Norwegian Cancer Society to be of the best
possible benefit to the cancer issue. This can occur both through commercial exploitation as well as by
publication and other forms of disseminating the research results.
The parties agree that 1/3 of the net income from any possible commercialisation will as a primary rule
be allocated to the institute/research environment by ${responsible institution} who has developed the
idea in line with ${responsible institution}'s guidelines. Revenues from commercialisable ideas that
arise in extension of research funds from the Norwegian Cancer Society will in this way go towards
further cancer research.
Protection
The project owner institution and any possible project partners must assess the need to protect project
results that may be of commercial value and, when the need dictates such, protect them. If the
legislation requires that the rights have to be registered in order to attain protection, then the project
owner institution must ensure that this registration is undertaken.
Information for the Technology Transfer Office (TTO)
The Norwegian Cancer Society desires that the results of research be of benefit to the patients. The
Norwegian Cancer Society thus has the right to divulge contact information and present the project
19receiving the grant to the TTO at the associated project owner institution, in order to arrange for
increased co-operation between the actors.
9. Release to the public and attribution of credit
The Norwegian Cancer Society may grant Norwegian cancer researchers research funds that
originate from gifts given by the Norwegian population. The donors trust that the money will be
administered in a good and justifiable manner. It thus is important that the Norwegian Cancer Society
be able to document how the funds are used, and thereby secure the most possible knowledge for the
population on how the funds collected are being administrated. Based on this, we expect that the
project owner institution and project manager will adhere to the following:
- The project owner institution and project manager must jointly contribute to the Norwegian
Cancer Society’s efforts being rendered visible to the general public, users and relevant
professional bodies. The Norwegian Cancer Society must be clearly rendered as the financier
of the research project being discussed and profiled using the Norwegian Cancer Society’s
name, for example by use of the designation "Norwegian Cancer Society Research Group" or
"The Norwegian Cancer Society's Group of Expertise for …", including in connection with
signage, on Web sites, in reports and other informational material. This must occur in dialogue
with the Norwegian Cancer Society, and the Norwegian Cancer Society will be of assistance
in procuring the requisite material.
- The Norwegian Cancer Society must be credited as the financing source in all publications
that are directly associated with the project.
- The Norwegian Cancer Society’s logo must be used in presentations, posters, publications, on
Web pages, annual reports, course materials, and the like.
- When the project owner institution or project manager makes statements about the project in
the media, the Norwegian Cancer Society must be credited as the financing source.
- The project owner institution and project manager must with no remuneration and as much as
possible contribute to the dissemination of research results.
The Norwegian Cancer Society has the right to release to the public the name of the project owner
institution, project manager, project title, project duration, project summary, popular science
explanation and its financial contribution. If the popular science presentation that was submitted with
the application is not adequate in terms of its form and content, then the Norwegian Cancer Society
may request that it be reformulated.
Unless there are special reasons that argue against it, the project owner institution must ensure that
the project results are published and disseminated as quickly as possible. Research-generated data
must be deemed to be publicly available if there are no special reasons that argue against it or
contractual terms and conditions or governmental rules exist that prevent this.
The Norwegian Cancer Society possesses the right to use the data in its work unless there are special
reasons that dictate to the contrary. What is meant by special reasons is protection of the project
owner institution's incorporeal rights, the risk of being plagiarised, breaches of non-disclosure
obligations, the risk of damage that such release to the public may cause to the project owner
institution's enterprise, as well as other reasons that make the requirement for release to the public
unreasonable in proportion to the interests of the project owner institution.
10. Indemnification and immunity from liability
The project owner institution bears the responsibility for the execution of the project not infringing upon
the rights of third parties, including third-party copyrights and other incorporeal rights, or in some other
manner that could bring about claims from third parties.
20The project owner institution must indemnify the Norwegian Cancer Society against all claims that
might arise in connection with the execution of the project, including claims that follow from
infringements of incorporeal rights.
The Norwegian Cancer Society is not legally or financially liable for damage or losses due to, among
other things, errors in or untrained use of equipment, methods or programs that are associated with
the project.
11. Force majeure
Each of the parties shall without undue delay notify the other parties if a force majeure situation
prevents the party concerned from fulfilling its obligations under the contract. None of the parties are
liable for a lack of adherence to their obligations under the contract in consequence of force majeure.
If force majeure endangers the project itself, then the parties must meet in order to negotiate
necessary adjustments to the project. If the parties do not reach agreement on such adjustments, then
the Norwegian Cancer Society may halt disbursements to the project.
12. Duration and cessation of the contract
The contract will cease without notification when the project has ended and its final report has been
submitted and approved, unless the contract period ceases earlier.
Ending of the contract by agreement
The parties may by written agreement wind up the contract before expiry of the project period.
Cancellation
Cancellation of the contract must occur in writing and must be justified.
The Norwegian Cancer Society may cancel the contract with immediate effect if the project owner
institution has significantly breached its obligations. A significant breach is deemed, among other
things, to comprise:
- the existence of significant deviations in relation to the progress plan or other conditions
governed in the contract
- the project owner institution breaking its obligations for reporting, cf. point 7.
- the grants disbursed being used in violation of the contract or what was agreed between the
parties
- the project owner institution conducting activities that are incompatible with the applicable
legislation or the Norwegian Cancer Society’s goals and guidelines, including ethical
guidelines
- the project owner institution not desiring to or not being able to complete the project
- central preconditions for the contractual relationship being abandoned, including the
Norwegian Cancer Society not having the requisite funds placed at its disposal, changes
being made in governmental regulations or other unforeseen circumstances arising that are of
essential significance to the execution of the project or the Norwegian Cancer Society’s ability
to contribute to it
The project owner institution may cancel the contract with immediate effect if the Norwegian Cancer
Society has significantly breached its obligations.
If the Norwegian Cancer Society cancels the contract due to a significant breach at the project owner
institution, then the Norwegian Cancer Society may require repayment of disbursed grants, with the
addition of late payment interest with respect to the applicable law concerning interest on late
payments, from the point in time of the cancellation.
21You can also read
